Ovarian cancer is the seventh most commonly diagnosed cancer in women worldwide and the leading cause of death among all malignancies of the female reproductive system (1, 2). Dysregulation of microRNA (miRNA) has been found to play a fundamental role in the onset, progression and dissemination of various cancers, including ovarian cancer. miRNAs have been… Read article →
The 3rd ACTC Advances in Circulating Tumor Cells Conference was held in Rhodes, Greece October 4-7, 2017. This idyllic island setting off the coast of Turkey provided a relaxed and welcoming atmosphere for discussing the latest advances in cancer and circulating tumor cell research. Talks were divided into 6 plenary lecture sessions consisting of: (1)… Read article →
Sometimes our lives get so busy that we don’t always appreciate the little things, such as enjoying a hot cup of tea on a sunny afternoon, or receiving a kind “thank you´´ from a colleague. It’s the same in research: there are multiple examples where the little things that matter the most get overlooked. miRNA… Read article →
Next-generation sequencing (NGS) is changing the face of cancer research and propelling us faster than ever toward smart, personalized solutions for attacking tumors. Recently we presented Cancer Research Week, a 4-part webinar series covering the latest advances in NGS to help you in your mission to reveal cancer’s secrets, from molecular barcodes to single cell sequencing. Did… Read article →
Cancer research has come a long way, and is accelerating even faster in the age of next-generation sequencing (NGS). Identifying mutations, discovering biomarkers, and profiling DNA and RNA from single cells has given us more specific and personalized insights than ever, and advances in NGS are largely to thank for these opportunities. This September, we’re offering a… Read article →
Looking for minireviews, pathway maps, publications and research solutions for specific genes and pathways? Just go to GeneGlobe! 